Analysts' Actions: BEN CNX EXC REGN STX

TheStreet.com

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Franklin Resources was downgraded to neutral, Sterne Agee said. Valuation call, based on a $170 price target.

Consol Energy was upgraded from equal-weight to overweight at Morgan Stanley. $44 price target. Company is leveraged to higher natural gas and thermal coal prices, Morgan Stanley said.

Exelon was downgraded from buy to hold, Wunderlich said. Company will likely see higher costs in the coming quarters.

Regeneron was upgraded from market perform to outperform at JMP. $290 price target. EYLEA should continue to drive growth and the late-stage cholesterol drug should be another catalyst, JMP Securities said.

Seagate was upgraded from hold to buy at Needham. $45 price target. Company continues to deliver solid cash flow, Needham said.


Allergan was upgraded from neutral to buy at Lazard. $115 price target. Selloff appears overdone, Lazard Capital Markets said.

Commvault was upgraded from neutral to overweight at Piper. Simpana 10 should drive market share gains, Piper Jaffray said.

Hyatt Hotels was cut from outperform to neutral at Credit Suisse. $41 price target. Company is posting disappointing growth, Credit Suisse said.

Jack Henry was downgraded to market perform at Wells. Valuation call, as the stock is up 33% over the past year, Wells Fargo said.


Nabors was upgraded to hold, Jefferies said. Valuation call, based on a $14 price target.

Regal-Beloit was upgraded from hold to buy at Keybanc. $75 price target. Pullback has created an attractive entry point, Keybanc said.

Superior Energy was upgraded from hold to buy at Jefferies. $33 price target. Pricing concerns have eased, Jefferies said.

STOCK COMMENTS/EPS CHANGES

Clean Harbors was removed from the best ideas list at Wedbush. Company cut its guidance. $70 price target.

Las Vegas Sands numbers were raised at Sterne Agee. Shares are now seen reaching $63, according to Sterne Agee. Estimates also increased, given higher growth in Asia. Buy rating.


Visa estimates, target were raised through 2015 at Credit Suisse. Company is buying back more stock. Outperform rating and new $185 price target, Credit Suisse said.

>To submit a news tip, email: tips@thestreet.com.

Follow TheStreet on Twitter and become a fan on Facebook.

EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he thinks could be potentially HUGE winners. Click here to see his holdings for FREE.

View Comments (0)